- Home
- CRNT vs BNTC Comparison
CRNT vs BNTC Comparison
Compare CRNT & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNT | BNTC |
|---|---|---|
| Founded | 1996 | 1995 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.5M | 405.7M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRNT | BNTC |
|---|---|---|
| Price | $2.08 | $12.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $4.00 | ★ $28.25 |
| AVG Volume (30 Days) | ★ 503.1K | 244.5K |
| Earning Date | 02-10-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $363,330,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.06 | N/A |
| P/E Ratio | $131.07 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.82 | $9.70 |
| 52 Week High | $5.73 | $17.15 |
Technical Indicators
Market Signals| Indicator | CRNT | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 49.95 | 50.25 |
| Support Level | $1.95 | $10.99 |
| Resistance Level | $2.13 | $12.99 |
| Average True Range (ATR) | 0.08 | 0.98 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 64.29 | 75.20 |
Price Performance
Historical ComparisonAbout CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.